Physician profile
Michael K Bednarz
NPI 1942290705
$28,720.49
in general payments reported to CMS, 2019-2025
19 companies · $4,400 in 2025
The $4,400 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $289 · 2020: $1,500 · 2021: $2,239 · 2022: $5,556 · 2023: $8,879 · 2024: $5,857 · 2025: $4,400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $4,941 · Food and Beverage: $3,183 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,000.00 |
| Travel and Lodging | $4,941.48 |
| Food and Beverage | $3,183.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $17,304.77 | 2021-2025 | |
| Arthrex, INC. | $4,777.22 | 2022-2024 | |
| Alpha Orthopedic Systems | $1,754.21 | 2021-2023 | |
| Intravu INC. | $1,572.35 | 2019-2020 | |
| Anika Therapeutics, INC. | $1,344.86 | 2021-2022 | |
| United Orthopedics LLC | $363.34 | 2024 | |
| Nevro Corp. | $289.70 | 2022-2024 | Senza |
| Trice Medical, INC. | $262.04 | 2023-2024 | |
| Globus Medical, INC. | $221.33 | 2025 | Senza |
| Access Pro Medical, LLC | $168.44 | 2023 | Matriderm |
| Medtronic, INC. | $145.47 | 2024 | Hawkone |
| Zyla Life Sciences, INC. | $142.73 | 2019 | |
| Biopoly LLC | $113.00 | 2024 | |
| Triad Life Sciences INC. | $112.65 | 2021-2022 | |
| Horizon Therapeutics Plc | $58.34 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $39.09 | 2021 | |
| Zimmer Biomet Holdings, INC. | $18.48 | 2021 | |
| Crossroads Extremity Systems, LLC | $16.96 | 2019 | |
| Arthrosurface Incorporated | $15.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bednarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.